1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Parenteral Nutrition Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Parenteral Nutrition Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Parenteral Nutrition Market Regional Analysis
6.2 Europe Parenteral Nutrition Market Revenue 2020-2030 (US$ Million)
6.3 Europe Parenteral Nutrition Market Forecast Analysis
7. Europe Parenteral Nutrition Market Analysis – by Nutrient Type
7.1 Single Dose Amino Acid Solution
- 7.1.1 Overview
- 7.1.2 Single Dose Amino Acid Solution: Europe Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Parenteral Lipid Emulsion
- 7.2.1 Overview
- 7.2.2 Parenteral Lipid Emulsion: Europe Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Carbohydrates
- 7.3.1 Overview
- 7.3.2 Carbohydrates: Europe Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Trace Elements
- 7.4.1 Overview
- 7.4.2 Trace Elements: Europe Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Vitamins and Minerals
- 7.5.1 Overview
- 7.5.2 Vitamins and Minerals: Europe Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Parenteral Nutrition Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Clinics
- 8.2.1 Overview
- 8.2.2 Clinics: Europe Parenteral Nutrition Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Parenteral Nutrition Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Parenteral Nutrition Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 9.2.1.1 Europe Parenteral Nutrition Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.1.1 UK: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.1.2 UK: Europe Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.2 Germany:
Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.2.1 Germany: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.2.2 Germany: Europe Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.3 France:
Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.3.1 France: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.3.2 France: Europe Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.4 Russia:
Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.4.1 Russia: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.4.2 Russia: Europe Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.5 Italy:
Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.5.1 Italy: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.5.2 Italy: Europe Parenteral Nutrition Market Breakdown, by End User
- 9.2.1.6 Rest of Europe:
Europe Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.2.1.6.2 Rest of Europe: Europe Parenteral Nutrition Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 ICU Medical Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Grifols SA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Pfizer Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Otsuka Pharmaceuticals Co Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 B Braun SE
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fresenius Kabi AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Aculife Healthcare Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Vifor Pharma Management AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations